Condition
High Ischemic Risk
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
4 treatments under study, led by Clopidogrelbased Dualantiplatelet Therapy
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Not Yet Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07543185Not ApplicableNot Yet Recruiting
Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome
NCT04989257Not ApplicableUnknownPrimary
24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial
Showing all 2 trials
Research Network
Common Treatments
- Clopidogrelbased Dualantiplatelet Therapy1
- Active Right Dlpfc Closedloop Fnirsbci Neurofeedback1
- Sham Right Dlpfc Closedloop Fnirsbci Neurofeedback1
- Ticagrelorbased Dualantiplatelet Therapy1
Active Sponsors
- Shenyang Medical College1
- Yonsei University1
Top Investigators
Yonsei University
Shenyang Medical College
Shenyang Medical College
Related Conditions
- Chronic Coronary Syndrome1
- Anxiety Disorder1